How different buprenorphine prescribing methods affect patient care for opioid use disorder
Official title: Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder
Funded at Boston Medical Center · NIH-11090363 · Data updated 2026-11-12
This study looks at how different ways of prescribing buprenorphine, a medication for treating opioid use disorder, can help keep patients in treatment longer, so we can find the best methods to support people on their recovery journey.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | May 15, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $186,527 |
| NIH project number | 5K08DA058052-03 |
| Project ID | NIH-11090363 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with opioid use disorder who are starting or currently receiving buprenorphine treatment.
✕Less likely to help
Patients who are not diagnosed with opioid use disorder or those who are not receiving buprenorphine treatment may not benefit from this research.
What this research studies
This research investigates how various prescribing strategies for buprenorphine, a medication used to treat opioid use disorder (OUD), influence patient retention in care. It aims to analyze current dosage practices and their effectiveness in keeping patients engaged in treatment over time. By examining different dosage regimens, the study seeks to identify which methods lead to better long-term outcomes for individuals struggling with OUD. The findings could help healthcare providers optimize treatment plans to improve patient adherence and success.
Why it matters
Potential benefit: If successful, this research could lead to improved retention rates in treatment for patients with opioid use disorder, ultimately reducing the risk of overdose and enhancing recovery outcomes.
How similar studies have gone: Previous research has shown that optimizing medication dosage can improve treatment retention in similar patient populations, suggesting that this approach may yield beneficial results.
Where this research is happening
-
Boston Medical Center
Boston, United States Active
Researchers
- Principal investigator: Tilhou, Alyssa — Boston Medical Center
- Study coordinator: Tilhou, Alyssa
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.